Provenance Wealth Advisors’s Regencell Bioscience RGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.48K Buy
+238
New +$1.38K ﹤0.01% 1862

Other funds holding RGC

Provenance Wealth Advisors's RGC Position: Q3 2026 in Review

Provenance Wealth Advisors opened a new position in Regencell Bioscience (RGC) in Q3 2026: 238 shares worth $1.48K. The stake represents ﹤0.01% of the portfolio and ranks #1862 among its holdings.

31 funds tracked by Wall St. Rank hold RGC as of Q3 2026.

  • Provenance Wealth Advisors held 238 shares of Regencell Bioscience worth $1.48K as of Q3 2026.
  • Regencell Bioscience was a new Provenance Wealth Advisors position in Q3 2026.
  • Regencell Bioscience made up ﹤0.01% of Provenance Wealth Advisors's portfolio in Q3 2026, its #1862 holding.
  • 31 funds tracked by Wall St. Rank held Regencell Bioscience as of Q3 2026.

Based on Provenance Wealth Advisors's 13F filing for Q3 2026, filed 30 Oct 2026.